ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

70
Analysis
Health CareHong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
Refresh
24 Mar 2017 16:32

Energy Medicine. Personal Experience. Impact. Growth in Asia. Ideas

This is an invest-able idea at the private level  with long term benefits. Both for the body, and for other ideas as well.Ever since I turned over...

Share
31 Oct 2016 09:52

TaiGen Sold Its Furaprevir for 25x of Market Capital

Summary What's new? Taigen and HEC Pharm announced a new joint venture.  HEC Pharm agrees Taigen to use its developed new drug Furaprevir...

Logo
Andrew Lu
304 Views
Share
16 Dec 2015 16:22

HEC ChangJiang Pharma IPO - Just a Manufacturing Shell

YiChang HEC ChangJiang Pharmaceuticals (YHCP) plans to raise US$160-215m through an issuance of primary shares in its IPO.We've worked along...

Logo
370 Views
Share
06 Feb 2015 15:02

Can Innovation labs be assessed to pick stocks for your portfolio?

Companies across different industries are building Innovation centers  in Singapore, Hong Kong and other cities across Asia and the rest of the...

Logo
672 Views
Share
22 Jan 2015 07:01

Hutchison Whampoa Restructuring: Next Move for Watson's?

The announced restructuring of Cheung Kong Limited and Hutchison Whampoa Limited has been well received on the HKEx. Hutchison shares have rallied...

Share
x